- Country: USA
- Summary: DRAGEN Iterative gVCF Genotyper (IGG) Caller
- UST Ref No: 123175963
- Deadline: 31 Jul 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75N95025Q00215
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to provide equipment for this requirement.
This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only.
BACKGROUND INFORMATION AND OBJECTIVE:
Our project aims to enhance our understanding of neurodegenerative diseases, specifically amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), through the detailed analysis of human DNA samples using state-of-the-art, short-read whole-genome sequencing. We will conduct association analyses to map the genetic factors that contribute to these human diseases, which claim the lives of thousands of Americans each year. Our findings will shed light on the complex genetic landscape of neurodegeneration and ultimately provide targets for therapeutic development.
GENERIC NAME OF PRODUCT:
Illumina Integrated gVCF Genotype (IGG) caller
SALIENT CHARACTERISTICS:
Capable vendors must demonstrate their ability provide the following brand name or equal items:
Must use the Illumina IGG caller to jointly call (i.e., merge) our existing single-sample gVCF files (n = 56,000). Must be capable of working with gVCFs that have been generated using the DRAGEN alignment pipeline (version 4.3). Must be able to retain the INFO and QUALITY CONTROL information embedd... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINDRAGEN Iterative gVCF Genotyper (IGG) Caller - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for DRAGEN Iterative gVCF Genotyper (IGG) Caller. This tender is published on USARFP under UST Ref No: 123175963 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-07-31.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
